BT

Bernard Thorens

NA Novo Nordisk A/S: 3 patents #460 of 1,775Top 30%
SA Sanofi: 3 patents #505 of 1,881Top 30%
E( Ecole Polytechnique Federale De Lausanne (Epfl): 1 patents #389 of 1,139Top 35%
UL Universite De Lausanne: 1 patents #16 of 56Top 30%
📍 Épalinges, CH: #12 of 139 inventorsTop 9%
Overall (All Time): #576,848 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
8852939 Use of Vgll3 activity modulator for the modulation of adipogenesis Diana Hall, Maria Jimenez, Carine Poussin 2014-10-07
8841270 Use of inhibitors of Zdhhc2 activity for modulation of adipogenesis Diana Hall, Maria Jimenez, Carine Poussin 2014-09-23
8759311 Use of siRNA targetting SIPA1L1 for the reduction of adipogenesis Diana Hall, Maria Jimenez, Carine Poussin 2014-06-24
6451601 Transiently immortalized cells for use in gene therapy Edward E. Baetge, Shou Wong, Philippe Dupraz 2002-09-17
6358739 Transiently immortalized cells Edward E. Baetge, Shou Wong, Philippe Dupraz 2002-03-19
6074875 Materials and methods relating to the regulation of polypeptide production in cells 2000-06-13
6051689 Receptor for the glucagon-like-peptide (GLP-1) 2000-04-18
5846747 Method for detecting glucagon-like peptide-1 antagonists and agonists Liselotte Bjerre Knudsen 1998-12-08
5670360 Mammalian receptors for glucagon-like-peptide-1 (GLP-1), corresponding DNA and recombinant expression systems, and screening assays for GLP-1 agonists and enhancers 1997-09-23